VAXXA Stock Overview
Operates an auction platform, vaxxa.se, which offers private individuals and companies to sell and buy used objects in vehicles, machinery, and construction industry.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Vaxxa AB Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 1.11 |
52 Week High | SEK 1.85 |
52 Week Low | SEK 0.68 |
Beta | 0.56 |
11 Month Change | 43.23% |
3 Month Change | 26.86% |
1 Year Change | -20.71% |
33 Year Change | -97.82% |
5 Year Change | -98.64% |
Change since IPO | -99.91% |
Recent News & Updates
Recent updates
Shareholder Returns
VAXXA | SE Entertainment | SE Market | |
---|---|---|---|
7D | 0.9% | -8.9% | -4.2% |
1Y | -20.7% | -33.5% | 12.5% |
Return vs Industry: VAXXA exceeded the Swedish Entertainment industry which returned -33.5% over the past year.
Return vs Market: VAXXA underperformed the Swedish Market which returned 12.5% over the past year.
Price Volatility
VAXXA volatility | |
---|---|
VAXXA Average Weekly Movement | 31.9% |
Entertainment Industry Average Movement | 6.0% |
Market Average Movement | 5.8% |
10% most volatile stocks in SE Market | 12.2% |
10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: VAXXA's share price has been volatile over the past 3 months.
Volatility Over Time: VAXXA's weekly volatility has increased from 23% to 32% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | 7 | Karl Frindberg | vaxxa.se |
Vaxxa AB operates an auction platform, vaxxa.se, which offers private individuals and companies to sell and buy used objects in vehicles, machinery, and construction industry. The company was formerly known as Augeo Group AB and changed its name to Vaxxa AB in July 2023. Vaxxa AB was incorporated in 2015 and is based in Stockholm, Sweden.
Vaxxa AB Fundamentals Summary
VAXXA fundamental statistics | |
---|---|
Market cap | SEK 36.97m |
Earnings (TTM) | -SEK 557.00k |
Revenue (TTM) | SEK 81.76m |
0.5x
P/S Ratio-66.4x
P/E RatioIs VAXXA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VAXXA income statement (TTM) | |
---|---|
Revenue | SEK 81.76m |
Cost of Revenue | SEK 74.35m |
Gross Profit | SEK 7.41m |
Other Expenses | SEK 7.97m |
Earnings | -SEK 557.00k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.017 |
Gross Margin | 9.06% |
Net Profit Margin | -0.68% |
Debt/Equity Ratio | 4.7% |
How did VAXXA perform over the long term?
See historical performance and comparison